Athira Pharma Inc
ATHA
Get informed when a big investor buys or sells
+ FollowMarket Cap$26.62M
Close$
$12.27
81.8% upside
Current Fair Value
81.8% upsideUndervalued by 81.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $26.62 Million |
|---|---|
| Enterprise Value | $-5,520,763.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-24.7 |
| Beta | 2.8 |
| Outstanding Shares | 19,027,087 |
Return
| Return on Equity | -262.49% |
|---|---|
| Return on Assets | -180.77% |
| Return on Invested Capital | -170.35% |
Valuation & Multiples
| P/E Ratio | -0.26 |
|---|---|
| PEG | -0.1 |
| Price to Sales | - |
| Price to Book Ratio | 3.38 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.05 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.13 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 7, 2026
EPS Estimate
$-1.90
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 32.61%▲ 23.60% |
|---|---|
| Total Invested | $46.70M▲ 512.59% |
| Investors Holding | 42▲ 9.00% |
ESG Score
No data